http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008532981-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-91
filingDate 2006-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008532981-A
titleOfInvention 2- (4-Oxo-4H-quinazolin-3-yl) acetamide and its use as a vasopressin V3 antagonist
abstract The present invention has the formula of 2- (4-oxo -4H- quinazolin-3-yl) for acetamide derivatives and particularly in the treatment of depression (I), to their use as vasopressin V 3 antagonists.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010173978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016117720-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013147117-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7071917-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018520195-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013537914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010502745-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018536685-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542264-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541057-B2
priorityDate 2005-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003523351-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59511795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409747204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421013547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409312501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59511789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425009679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466895001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44203076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54329184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59511790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413333370

Total number of triples: 52.